References
- Screaton G. R., Bell M. V., Jackson D. G., Cornelis F. B., Gerth U., Bell J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. U. S. A. 1992; 89(24)12160–12164, [PUBMED], [INFOTRIEVE], [CSA]
- Naot D., Sionov R. V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 1997; 71: 241–319, [CSA]
- Bennett K. L., Jackson D. G., Simon J. C., Tanczos E., Peach R., Modrell B., Stamenkovic I., Plowman G., Aruffo A. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 1995; 128(4)687–698, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Skelton T. P., Zeng C., Nocks A., Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 1998; 140(2)431–446, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sneath R. J., Mangham D. C. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol. 1998; 51(4)191–200, [PUBMED], [INFOTRIEVE]
- Heider K. H., Hofmann M., Hors E., van den Berg F., Ponta H., Herrlich P., Pals S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol. 1993; 120(1)227–233, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mulder J. W., Kruyt P. M., Sewnath M., Oosting J., Seldenrijk C. A., Weidema W. F., Offerhaus G. J., Pals S. T. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344(8935)1470–1472, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yamaguchi A., Urano T., Goi T., Saito M., Takeuchi K., Hirose K., Nakagawara G., Shiku H., Furukawa K. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J. Clin. Oncol. 1996; 14(4)1122–1127, [PUBMED], [INFOTRIEVE]
- Ropponen K. M., Eskelinen M. J., Lipponen P. K., Alhava E., Kosma V. M. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand. J. Gastroenterol. 1998; 33(3)301–309, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wielenga V. J., Heider K. H., Offerhaus G. J., Adolf G. R., van den Berg F. M., Ponta H., Herrlich P., Pals S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 1993; 53(20)4754–4756, [PUBMED], [INFOTRIEVE]
- Kim H., Yang X. L., Rosada C., Hamilton S. R., August J. T. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys. 1994; 310(2)504–507, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bhatavdekar J. M., Patel D. D., Chikhlikar P. R., Trivedi T. I., Gosalia N. M., Ghosh N., Shah N. G., Vora H. H., Suthar T. P. Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas. Ann. Surg. Oncol. 1998; 5(6)495–501, [PUBMED], [INFOTRIEVE], [CSA]
- Wielenga V. J., van der Neut R., Offerhaus G. J., Pals S. T. CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Adv. Cancer Res. 2000; 77: 169–187, [PUBMED], [INFOTRIEVE], [CSA]
- Kuniyasu H., Oue N., Tsutsumi M., Tahara E., Yasui W. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. Clin. Cancer Res. 2001; 7(12)4067–4072, [PUBMED], [INFOTRIEVE], [CSA]
- Koretz K., Moller P., Lehnert T., Hinz U., Otto H. F., Herfarth C. Effect of CD44v6 on survival in colorectal carcinoma. Lancet 1995; 345(8945)327–328, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Coppola D., Hyacinthe M., Fu L., Cantor A. B., Karl R., Marcet J., Cooper D. L., Nicosia S. V., Cooper H. S. CD44V6 expression in human colorectal carcinoma. Human Pathol. 1998; 29(6)627–635, [CSA]
- Finke L. H., Terpe H. J., Zorb C., Haensch W., Schlag P. M. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1995; 345(8949)583, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nanashima A., Yamaguchi H., Sawai T., Yamaguchi E., Kidogawa H., Matsuo S., Yasutake T., Tsuji T., Jibiki M., Nakagoe T., Ayabe H. Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors. Dig. Dis. Sci. 2001; 46(8)1623–1628, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Khoursheed M., Mathew T. C., Makar R. R., Sonia L., Abul H., Asfar S., Al-Sayer H., Dashti H. M., Al-Bader A. Expression of CD44s in human colorectal cancer. Pathol. Oncol. Res. 2002; 8(3)170–174, [PUBMED], [INFOTRIEVE], [CSA]
- Visca P., Del Nonno F., Botti C., Marandino F., Sebastiani V., Di Tondo U., Donnorso R. P., Trombetta G., Filippi S., Alo P. L. Role and prognostic significance of CD44s expression in colorectal cancer. Anticancer Res. 2002; 22(5)2671–2675, [PUBMED], [INFOTRIEVE], [CSA]
- Sokmen S., Lebe B., Sarioglu S., Fuzun M., Terzi C., Kupelioglu A., Ellidokuz H. Prognostic value of CD44 expression in colorectal carcinomas. Anticancer Res. 2001; 21(6A)4121–4126, [PUBMED], [INFOTRIEVE], [CSA]
- Hermaneck P., Sobin L. UICC TNM Classification of Malignant Tumors6th Ed. Springer, Berlín 2002
- Dukes C. The classification of cancer of the rectum. J. Pathol. Bacteriol. 1932; 35: 323–332
- Broders A. The grading of carcinoma. Minn. Med. 1925; 8: 726
- Hedley D. W., Shankey T. V., Wheeless L. L. DNA cytometry consensus conference. Cytometry 1993; 14(5)471, [PUBMED], [INFOTRIEVE]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254, [PUBMED], [INFOTRIEVE]
- Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–481, [CSA]
- Mantel N., Myers M. Problems of convergence of maximun likehood iterative procedures in multiparameter situations. J. Am. Stat. Assoc. 1971; 66: 484–491
- Llaneza A., Vizoso F., Rodriguez J. C., Raigoso P., Garcia-Muniz J. L., Allende M. T., Garcia-Moran M. Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br. J. Surg. 2000; 87(12)1690–1696, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gunthert U. CD44 in malignant disorders. Curr. Top. Microbiol. Immunol. 1996; 213(Pt 1)271–285, [PUBMED], [INFOTRIEVE]
- Aruffo A., Stamenkovic I., Melnick M., Underhill C. B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61(7)1303–1313, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Underhill C. CD44: the hyaluronan receptor. J. Cell. Sci. 1992; 103(Pt 2)293–298, [PUBMED], [INFOTRIEVE]
- Harada N., Mizoi T., Kinouchi M., Hoshi K., Ishii S., Shiiba K., Sasaki I., Matsuno S. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int. J. Cancer 2001; 91(1)67–75, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Koopman G., van Kooyk Y., de Graaff M., Meyer C. J., Figdor C. G., Pals S. T. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol. 1990; 145(11)3589–3593, [PUBMED], [INFOTRIEVE]
- Jalkanen S., Saari S., Kalimo H., Lammintausta K., Vainio E., Leino R., Duijvestijn A. M., Kalimo K. Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J. Invest. Dermatol. 1990; 94(6)786–792, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wielenga V. J., van der Voort R., Taher T. E., Smit L., Beuling E. A., Krimpen vanC., Spaargaren M., Pals S. T. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am. J. Pathol. 2000; 157(5)1563–1573, [PUBMED], [INFOTRIEVE]
- Yamada Y., Itano N., Narimatsu H., Kudo T., Hirohashi S., Ochiai A., Niimi A., Ueda M., Kimata K. Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn. J. Cancer Res. 1999; 90(9)987–992, [PUBMED], [INFOTRIEVE], [CSA]
- Asao T., Nakamura J., Shitara Y., Tsutsumi S., Mochiki E., Shimura T., Takenoshita S., Kuwano H. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma. Dis. Colon Rectum 2000; 43(9)1250–1254, discussion 1254–1255[PUBMED], [INFOTRIEVE], [CSA]
- Gilcrease M. Z., Guzman-Paz M., Niehans G., Cherwitz D., McCarthy J. B., Albores-Saavedra J. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Cancer 1999; 86(11)2320–2326, [PUBMED], [INFOTRIEVE], [CROSSREF]